B Braun Medical Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN MEDICAL
B BRAUN MEDICAL has sixteen approved drugs.
There are three US patents protecting B BRAUN MEDICAL drugs.
Summary for B Braun Medical
| US Patents: | 3 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 16 |
Drugs and US Patents for B Braun Medical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-001 | Apr 30, 2015 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| B Braun Medical | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | 8,969,412 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| B Braun Medical | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207966-001 | Oct 27, 2020 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| B Braun Medical | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 209705-003 | Feb 27, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for B Braun Medical
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun Medical | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | 8,969,412 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for B Braun Medical Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | I595876 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2014091420 | ⤷ Start Trial |
| South Africa | 201504618 | ⤷ Start Trial |
| Spain | 2628076 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Medical Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1259550 | SZ 47/2008 | Austria | ⤷ Start Trial | PRODUCT NAME: SUGAMMADEX; 6-PER-DEOXY-6-PER-(2-CARBOXYETHYL) THIO-Y-CYCLODEXTRIN UND PHARMAZEUTISCH VERTRÄGLICHES SALZ HIERVON |
| 1020461 | 300482 | Netherlands | ⤷ Start Trial | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| 3752510 | PA2025542 | Lithuania | ⤷ Start Trial | PRODUCT NAME: VANZACAFTOR, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREFERABLY ACALCIUM SALT THEREOF; REGISTRATION NO/DATE: EU/1/25/1943 20250630 |
| 2603514 | CA 2019 00015 | Denmark | ⤷ Start Trial | PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
